Pharmaceutical Technology June Issue: Better Connected: The Value of Connected Drug Delivery

Having trouble viewing this e-mail? CLICK HERE

June 2020
Volume 44, No. 6

| COVER STORY |

Better Connected: The Value of Connected Drug Delivery

Felicity Thomas

Connected delivery solutions can provide value to industry and patients, through improved medication adherence and outcome optimization.
read more

| DEVELOPMENT |

Formulating for Convenience and Compliance

Cynthia A. Challener

The correct mix of excipients is crucial to the success of fast dissolving/orally disintegrating dosage forms.
read more

PharmTech June Issue


advertisement

Reducing Risk with Abuse‑Deterrent Formulations Felicity Thomas Increasing prevalence of drug misuse and abuse is driving a heightened and more stringent approach to abuse-deterrent formulations. read more \| MANUFACTURING \| Why Do Disinfectant Residues Matter? Madison Hoal, Donald Singer Consider how to assess risks and understand possible sources of disinfectant residues in pharmaceutical manufacturing. read more ADVERTISEMENT Exclusive Interview from AAPS: Comparative Evaluation of Commonly Employed Plasticizers in Soft Gelatin Capsules Sponsored by: SPI Learn More ›› \| PEER-REVIEWED RESEARCH \| Approaches to Alleviating Subcutaneous Injection-Site Pain for Citrate Formulations Arvind Srivastava, Ger Brophy, Meera Agarkhed The authors compare formulations containing citrate with other buffers in reducing subcutaneous injection-site pain and discuss a formulation and excipients selection strategy. read more \| QUALITY/REGULATIONS \| Good Manufacturing Practices: Challenges with Compliance Lauren Lavelle The complexity of biologics and the use of new technologies present challenges for complying with CGMPs. read more \| OPERATIONS \| Intelligent Packaging Promotes Interaction with Patients Hallie Forcinio Advances in intelligent technologies for pharmaceutical packaging improve online productivity, authenticate product, and boost patient adherence. read more Finding New Efficiencies in Clinical Trial Logistics Agnes Shanley The COVID-19 pandemic has led to increased demand for direct-to-patient shipments, challenging cold-chain specialists to become more agile and to strengthen their global distribution networks. read more \| OUTSOURCING \| The Importance of Partnering for Bioanalytical Studies Feliza Mirasol Bioanalytical studies are an important aspect of biologic drug development that may necessitate partnering with bioanalysis experts. read more \| FROM THE EDITOR \| Are We All In This Together? Rita C. Peters Achieving herd immunity will require testing, data, a vaccine, and public support. read more \| US REGULATORY WATCH \| Generic Drugs in Spotlight as Pandemic Creates Shortages Jill Wechsler FDA and the US Congress support innovation and access to cheaper medicines. read more \| ASK THE EXPERT \| Following Guidelines During a Crisis Susan J. Schniepp Products must be manufactured in accordance with appropriate regulatory requirements, even during a pandemic, says Susan J. Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates. read more